Pharma Bio Serv Inc (PBSV) 1.2000 $PBSV
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2015
ACCESSWIRE - Tue Mar 17, 4:10PM CDT
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2015 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues for the three months ended January 31, 2015 were $5.9 million, a decrease of approximately $1.1 million, or 16%, when compared to the same period last year. This decline is mainly attributable to a $1.5 and $0.3 million revenue decrease in the United States and Europe consulting markets, respectively, offset by a gain in the Puerto Rico consulting business of approximately $0.7 million, of which $0.4 million are attributable to projects in Latin America that are managed from Puerto Rico. Other Company divisions sustained minor revenue gains/losses or remained constant, when compared to the same period last year.
Pharma-Bio Serv Announces Total Net Revenues of $27.6 Million and Net Income of $2.4 Million for the Year Ended October 31, 2014
ACCESSWIRE - Thu Jan 29, 5:17PM CST
DORADO, PUERTO RICO / ACCESSWIRE / January 29, 2015 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced total net revenues of $27.6 million for the year ended October 31, 2014, a decrease of approximately $5.5 million, or 16.7%, when compared to the same period last year. The revenue decrease is mainly attributable to a decline from consulting projects in the United States and Europe.
Pharma-Bio Serv Appoints Víctor Sánchez as President and Chief Executive Officer Effective January 1, 2015
ACCESSWIRE - Tue Dec 02, 8:01AM CST
DORADO, PUERTO RICO / ACCESSWIRE / December 2, 2014 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, announced today that the Board of Directors has appointed Víctor Sánchez as President and Chief Executive Officer, effective January 1, 2015.
MRK: 60.01 (-0.22)
Pharma-Bio Serv Retains T.R. Winston & Company to Enhance Growth Opportunities Through Business Development, Mergers & Acquisitions, and to Review Strategic Alternatives
ACCESSWIRE - Mon Dec 01, 8:01AM CST
DORADO, PUERTO RICO / ACCESSWIRE / December 1, 2014 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, announced today that it has retained T.R. Winston & Company (T.R. Winston) in order to assist Pharma-Bio Serv in enhancing the Company's growth strategy through business development, and mergers and acquisitions.
Pharma-Bio Serv to Present at the LD Micro Conference on December 2, 2014
ACCESSWIRE - Tue Nov 25, 3:11PM CST
DORADO, PUERTO RICO / ACCESSWIRE / November 25, 2014 / Pharma-Bio Serv, Inc. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that the Company will be a featured presenter at the LD MICRO Main Event VII Conference at the Luxe Sunset, Los Angeles, CA on Tuesday, December 2, 2014 at 3:00pm PDT, Track 2. The Company will be available for investor one-on-one meetings on December 2 and 3, 2014.
Pharma-Bio Serv Signs Strategic Collaboration Agreement With Quality Technical Iberica, S.L.
Marketwired - Thu Oct 09, 3:05PM CDT
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that it has signed a three-year strategic collaboration agreement with Quality Technical Iberica, S.L ("QTI"
, a Spain-based company specializing in Calibrations, Validation, HVAC and Clean Room Qualification services.
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2014
Marketwire - Mon Sep 15, 3:40PM CDT
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today net revenues for the three and nine months ended July 31, 2014 were $6.8 and $20.4 million, respectively, a decrease of approximately $1.5 and $3.9 million, or 18.3% and 15.9%, respectively, when compared to the same periods last year. This decrease is mainly attributable to a decline in revenues from projects in the United States, Europe and Puerto Rico consulting markets and the Lab for $0.9, $0.4, $0.1 and $0.2 million, respectively, for the three-month period ended July 31, 2014, and $2.2, $0.9, $0.4 and $0.3 million, respectively, for the nine-month period ended July 31, 2014. Other Company divisions sustained minor revenue gains/losses or remained constant, when compared to the same period last year.
Pharma-Bio Serv to Present at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014
Marketwire - Mon Aug 25, 7:06AM CDT
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that the Company will be a featured presenter at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014 at the New York Palace Hotel in New York City.
Pharma-Bio Serv Announces Stock Repurchase Program and Results for the Quarter Ended April 30, 2014
Marketwire - Wed Jun 18, 1:22AM CDT
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that its Board of Directors has authorized a stock repurchase program to purchase up to 2 million shares of its outstanding common stock. The timing, manner, price and amount of any repurchases will be at the discretion of the Company, subject to the requirements of the Securities Exchange Act of 1934, as amended, and related rules. The program does not oblige the Company to repurchase any shares and it may be modified, suspended or terminated at any time and for any reason. No shares will be repurchased directly from directors or officers of the Company.
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2015
ACCESSWIRE - Tue Mar 17, 4:10PM CDT
DORADO, PUERTO RICO / ACCESSWIRE / March 17, 2015 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues for the three months ended January 31, 2015 were $5.9 million, a decrease of approximately $1.1 million, or 16%, when compared to the same period last year. This decline is mainly attributable to a $1.5 and $0.3 million revenue decrease in the United States and Europe consulting markets, respectively, offset by a gain in the Puerto Rico consulting business of approximately $0.7 million, of which $0.4 million are attributable to projects in Latin America that are managed from Puerto Rico. Other Company divisions sustained minor revenue gains/losses or remained constant, when compared to the same period last year.
Pharma-Bio Serv Announces Total Net Revenues of $27.6 Million and Net Income of $2.4 Million for the Year Ended October 31, 2014
ACCESSWIRE - Thu Jan 29, 5:17PM CST
DORADO, PUERTO RICO / ACCESSWIRE / January 29, 2015 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced total net revenues of $27.6 million for the year ended October 31, 2014, a decrease of approximately $5.5 million, or 16.7%, when compared to the same period last year. The revenue decrease is mainly attributable to a decline from consulting projects in the United States and Europe.
Pharma-Bio Serv Appoints Víctor Sánchez as President and Chief Executive Officer Effective January 1, 2015
ACCESSWIRE - Tue Dec 02, 8:01AM CST
DORADO, PUERTO RICO / ACCESSWIRE / December 2, 2014 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, announced today that the Board of Directors has appointed Víctor Sánchez as President and Chief Executive Officer, effective January 1, 2015.
MRK: 60.01 (-0.22)
Pharma-Bio Serv Retains T.R. Winston & Company to Enhance Growth Opportunities Through Business Development, Mergers & Acquisitions, and to Review Strategic Alternatives
ACCESSWIRE - Mon Dec 01, 8:01AM CST
DORADO, PUERTO RICO / ACCESSWIRE / December 1, 2014 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, announced today that it has retained T.R. Winston & Company (T.R. Winston) in order to assist Pharma-Bio Serv in enhancing the Company's growth strategy through business development, and mergers and acquisitions.
Pharma-Bio Serv to Present at the LD Micro Conference on December 2, 2014
ACCESSWIRE - Tue Nov 25, 3:11PM CST
DORADO, PUERTO RICO / ACCESSWIRE / November 25, 2014 / Pharma-Bio Serv, Inc. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that the Company will be a featured presenter at the LD MICRO Main Event VII Conference at the Luxe Sunset, Los Angeles, CA on Tuesday, December 2, 2014 at 3:00pm PDT, Track 2. The Company will be available for investor one-on-one meetings on December 2 and 3, 2014.
Pharma-Bio Serv Signs Strategic Collaboration Agreement With Quality Technical Iberica, S.L.
Marketwired - Thu Oct 09, 3:05PM CDT
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that it has signed a three-year strategic collaboration agreement with Quality Technical Iberica, S.L ("QTI"
, a Spain-based company specializing in Calibrations, Validation, HVAC and Clean Room Qualification services. Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2014
Marketwire - Mon Sep 15, 3:40PM CDT
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today net revenues for the three and nine months ended July 31, 2014 were $6.8 and $20.4 million, respectively, a decrease of approximately $1.5 and $3.9 million, or 18.3% and 15.9%, respectively, when compared to the same periods last year. This decrease is mainly attributable to a decline in revenues from projects in the United States, Europe and Puerto Rico consulting markets and the Lab for $0.9, $0.4, $0.1 and $0.2 million, respectively, for the three-month period ended July 31, 2014, and $2.2, $0.9, $0.4 and $0.3 million, respectively, for the nine-month period ended July 31, 2014. Other Company divisions sustained minor revenue gains/losses or remained constant, when compared to the same period last year.
Pharma-Bio Serv to Present at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014
Marketwire - Mon Aug 25, 7:06AM CDT
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that the Company will be a featured presenter at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014 at the New York Palace Hotel in New York City.
Pharma-Bio Serv Announces Stock Repurchase Program and Results for the Quarter Ended April 30, 2014
Marketwire - Wed Jun 18, 1:22AM CDT
Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that its Board of Directors has authorized a stock repurchase program to purchase up to 2 million shares of its outstanding common stock. The timing, manner, price and amount of any repurchases will be at the discretion of the Company, subject to the requirements of the Securities Exchange Act of 1934, as amended, and related rules. The program does not oblige the Company to repurchase any shares and it may be modified, suspended or terminated at any time and for any reason. No shares will be repurchased directly from directors or officers of the Company.
